Runben Biotechnology Co., Ltd. (SHA:603193)

China flag China · Delayed Price · Currency is CNY
34.87
+1.85 (5.60%)
Apr 24, 2025, 2:45 PM CST
111.08%
Market Cap 13.36B
Revenue (ttm) 1.25B
Net Income (ttm) 306.18M
Shares Out 404.59M
EPS (ttm) 0.76
PE Ratio 43.48
Forward PE 42.58
Dividend 0.18 (0.53%)
Ex-Dividend Date Oct 30, 2024
Volume 5,927,246
Average Volume 3,389,362
Open 32.80
Previous Close 33.02
Day's Range 32.80 - 35.50
52-Week Range 15.80 - 37.99
Beta n/a
RSI 49.05
Earnings Date Apr 25, 2025

About Runben Biotechnology

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 2013 and is based in Guangzhou, China.Runben Biotechnology Co., Ltd. operates as a subsidiary of Guangzhou Zhuofan Investment Holding Co., Ltd [Read more]

Founded 2013
Employees 917
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603193
Full Company Profile

Financial Performance

In 2023, Runben Biotechnology's revenue was 1.03 billion, an increase of 20.66% compared to the previous year's 856.09 million. Earnings were 226.03 million, an increase of 41.23%.

Financial Statements

News

There is no news available yet.